SAREPTA THERAPEUTICS INC
SRPTNASDAQ🏆 #1584 by market capEarnings Nov 4US Equity
$18.22▲ $1.10 (+6.05%)
Live1h—
24h▲ 6.0%
7d▲ 14.4%
14d▲ 17.3%
30d▼ 3.2%
1y▼ 3.1%
🏦Market Cap
$1.92B
Small Cap
📈Revenue Growth (YoY)
-20.4%
Declining
📊Gross Margin
67.5%
High
💵FCF Margin
16.4%
Healthy
⚖️P/S Ratio
0.9x
Cheap
Otter Score
64
Fair
📊
Analyst Ratings
Price
$18.22
Total
55
Raised
7
Lowered
8
Avg PT
$25.00
| Institution | Action | Rating | Date |
|---|---|---|---|
Wolfe Research | Upgraded | Peer Perform → Outperform | 2026-07-09 |
Piper Sandler | Reiterated | Neutral | 2026-07-09 |
HC Wainwright & Co. | Reiterated | Sell | 2026-04-16 |
Citigroup | Reiterated | Sell | 2026-03-26 |
Needham | Reiterated | Underperform | 2026-03-26 |
Oppenheimer | Reiterated | Outperform | 2026-03-19 |
Mizuho | Reiterated | Outperform | 2026-03-13 |
Wells Fargo | Reiterated | Overweight | 2026-02-27 |
Wedbush | Reiterated | Outperform | 2026-01-23 |
Guggenheim | Reiterated | Buy | 2025-11-05 |
Barclays | Reiterated | Equal Weight | 2025-11-05 |
Baird | Reiterated | Neutral | 2025-11-04 |
BMO Capital | Upgraded | Market Perform → Outperform | 2025-09-22 |
Leerink Partners | Reiterated | Market Perform | 2025-09-09 |
B of A Securities | Reiterated | Underperform | 2025-08-21 |
Deutsche Bank | Reiterated | Sell | 2025-08-15 |
Goldman Sachs | Reiterated | Neutral | 2025-08-07 |
Morgan Stanley | Reiterated | Equal Weight | 2025-07-29 |
JP Morgan | Upgraded | Underweight → Neutral | 2025-07-29 |
Jefferies | Reiterated | Buy | 2025-07-24 |
Leerink Swann | Downgraded | Outperform → Market Perform | 2025-07-21 |
UBS | Downgraded | Buy → Neutral | 2025-07-21 |
RBC Capital | Reiterated | Sector Perform | 2025-07-17 |
William Blair | Downgraded | Outperform → Market Perform | 2025-06-20 |
Scotiabank | Upgraded | Sector Perform → Sector Outperform | 2025-06-06 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-05-07 |
Evercore ISI Group | Reiterated | Outperform | 2024-11-07 |
Credit Suisse | Reiterated | Neutral | 2023-06-23 |
SMBC Nikko | Reiterated | Outperform | 2023-04-26 |
TD Cowen | Reiterated | Outperform | 2023-03-22 |
SVB Leerink | Reiterated | Outperform | 2023-01-20 |
BTIG | Reiterated | Buy | 2022-12-22 |
Raymond James | Downgraded | Outperform → Market Perform | 2021-01-08 |
Berenberg | Reiterated | Hold | 2020-11-11 |
PiperJaffray | Reiterated | Overweight | 2019-12-13 |
Janney Capital | Reiterated | Buy | 2019-12-13 |
Janney Montgomery Scott | Reiterated | Buy | 2019-12-13 |
Citi | Reiterated | Buy | 2019-11-18 |
Guggenheim Securities | Reiterated | Buy | 2019-11-01 |
Bank of America | Reiterated | Buy | 2019-08-20 |
Nomura | Reiterated | Buy | 2019-02-28 |
Bernstein | Reiterated | Outperform | 2018-10-12 |
H.C. Wainwright | Reiterated | Buy | 2018-06-19 |
BTIG Research | Reiterated | Buy | 2018-06-15 |
SunTrust Robinson Humphrey | Upgraded | Hold → Buy | 2017-04-05 |
Cowen & Co. | Upgraded | Market Perform → Outperform | 2016-09-20 |
JMP Securities | Downgraded | Market Perform → Underperform | 2016-03-23 |
Roth Capital | Reiterated | Buy | 2015-08-26 |
Canaccord Genuity | Upgraded | Hold → Buy | 2015-05-20 |
Stifel Nicolaus | Downgraded | Buy → Hold | 2014-10-27 |
Stifel | Downgraded | Buy → Hold | 2014-10-27 |
WBB Securities | Reiterated | Speculative Buy → Buy | 2014-07-29 |
Burrill & Company | Downgraded | Market Outperform → Market Perform | 2013-07-24 |
Dawson James | Reiterated | Market Perform → Perform | 2012-11-27 |
ThinkEquity | Reiterated | Buy | 2012-08-27 |
One row per institution, most recent rating